Overview

Bial Biotech is focused on innovative drug development in the field of neurodegeneration. Our strategy leverages the “clinically validated” link between lysosomal-based genetic disorders and neurodegenerative diseases and has established a unique and effective molecular platform for novel drug discovery. Our lead program targets Gaucher-related neurodegeneration, Parkinson’s disease and other synucleinopathies.

See all Members